Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jun 9;95(12):7151-6.
doi: 10.1073/pnas.95.12.7151.

Bradykinin inhibits M current via phospholipase C and Ca2+ release from IP3-sensitive Ca2+ stores in rat sympathetic neurons

Affiliations

Bradykinin inhibits M current via phospholipase C and Ca2+ release from IP3-sensitive Ca2+ stores in rat sympathetic neurons

H Cruzblanca et al. Proc Natl Acad Sci U S A. .

Abstract

A variety of intracellular signaling pathways can modulate the properties of voltage-gated ion channels. Some of them are well characterized. However, the diffusible second messenger mediating suppression of M current via G protein-coupled receptors has not been identified. In superior cervical ganglion neurons, we find that the signaling pathways underlying M current inhibition by B2 bradykinin and M1 muscarinic receptors respond very differently to inhibitors. The bradykinin pathway was suppressed by the phospholipase C inhibitor U-73122, by blocking the IP3 receptor with pentosan polysulfate or heparin, and by buffering intracellular calcium, and it was occluded by allowing IP3 to diffuse into the cytoplasm via a patch pipette. By contrast, the muscarinic pathway was not disrupted by any of these treatments. The addition of bradykinin was accompanied by a [Ca2+]i rise with a similar onset and time to peak as the inhibition of M current. The M current inhibition and the rise of [Ca2+]i were blocked by depletion of Ca2+ internal stores by thapsigargin. We conclude that bradykinin receptors inhibit M current of sympathetic neurons by activating phospholipase C and releasing Ca2+ from IP3-sensitive Ca2+ stores, whereas muscarinic receptors do not use the phospholipase C pathway to inhibit M current channels.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intracellular BAPTA blocks modulation of M current by BK. Symbols represent the amplitude of M current deactivation measured every 4 s. BK and oxo-M were applied as indicated by the horizontal bars. (A) BK elicits a strong inhibition of M current (triangles) in a neuron dialyzed with 0.1 mM BAPTA. Voltage protocol and M current recording for the control (a) and during BK exposure (b) are shown on the right. Dashed line is the zero current level. (B) BK (triangles), but not oxo-M (squares), fails to inhibit M current in a neuron dialyzed with a 20 mM BAPTA/10 mM Ca2+ pipette solution. M current records from the control condition (a), with BK (b) and oxo-M (c) shown on the right. (C) Bar plot of the mean suppression (±SEM) of M current by BK (50 nM) and oxo-M (10 μM) with different internal solutions. The number of cells tested for each condition is in parentheses. M current records in the high 20 mM BAPTA pipette solutions were taken 9 min after breakthrough of the patch membrane.
Figure 2
Figure 2
BK raises [Ca2+]i to inhibit M current. Simultaneous recordings of [Ca2+]i and M current were done in a neuron loaded with indo-1 dye through the patch pipette (0.1 mM BAPTA/0.1 mM indo-1). In this neuron, BK raised [Ca2+]i (continuous trace) from 105 nM to 218 nM. The dashed line is the basal [Ca2+]i level. For comparison, the M current data (circles) were inverted (vertical bar) and aligned to match the amplitude of the [Ca2+]i signal.
Figure 3
Figure 3
Suppression of M current by BK is attenuated by the PLC inhibitor U-73122. Cells were incubated for 30 min with U-73122 (1 μM) or U-73343 (1 μM). BK (100 nM) and oxo-M (5 μM) were applied as indicated by the horizontal bars. (A) U-73122 prevents M current suppression by BK (triangles) but not by oxo-M (squares). (B) The inactive analog U-73343 does not block modulation of M current by BK. (C) Mean (±SEM) inhibition of M current by BK or by oxo-M in control cells (open bars) and in neurons treated with U-73343 (dashed bar) or U-73122 (solid bars).
Figure 4
Figure 4
Antagonists of the IP3 receptor selectively disrupt the BK pathway. Neurons were dialyzed with PPS or heparin for 14 min before M current recording. Mean (±SEM) inhibition of M current by BK (100 nM) and oxo-M (10 μM) in control cells (open bars) and in neurons dialyzed with PPS (solid bars) or heparin (dashed bar). PPS (100 μg/ml) disrupts M current inhibition by BK but not by oxo-M. Heparin (200 μg/ml) was less effective than PPS to block the BK-activated pathway.
Figure 5
Figure 5
IP3 occludes the inhibitory action of BK on M current. M current records were taken 10 min after breakthrough of the patch membrane. (A Left) In a control cell, BK suppresses M current. (A Right) In a neuron dialyzed with IP3 (100 μM), BK does not inhibit M current well (triangles), whereas oxo-M does (squares). (B) Mean inhibition (±SEM) of M current by BK in control (open bar) and IP3-loaded cells (solid bar).
Figure 6
Figure 6
Thapsigargin prevents the BK-evoked increase of [Ca2+]i and suppression of M current. (A) In a cell treated with thapsigargin (5 μM) for 13 min, BK does not inhibit M current. (Inset) Thapsigargin transiently raises [Ca2+]i from 92 to 210 nM and blocks a further rise of [Ca2+]i by BK (data from a different cell). (B) Mean (±SEM) M current inhibition by BK (100 nM) or oxo-M (10 μM) in control cells (open bars) and in neurons treated with thapsigargin (Thapsi., solid bars).

References

    1. Hille B. Trends Neurosci. 1994;17:531–536. - PubMed
    1. Bernheim L, Beech D J, Hille B. Neuron. 1991;6:859–867. - PubMed
    1. Shapiro M S, Wollmuth L P, Hille B. Neuron. 1994;12:1319–1329. - PubMed
    1. Lewis D L, Ikeda S R. Neuroendocrinology. 1997;66:235–245. - PubMed
    1. Lee S B, Rhee S G. Curr Opin Cell Biol. 1995;7:183–189. - PubMed

Publication types

MeSH terms

LinkOut - more resources